Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
21 February 2014Website:
http://www.semlerscientific.comNext earnings report:
04 November 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | 14 min agoDividend
Analysts recommendations
Institutional Ownership
SMLR Latest News
SANTA CLARA, Calif. , Nov. 4, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today reported financial results for the third quarter ended September 30, 2024.
SANTA CLARA, Calif. , Oct. 21, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced that it will report financial results for the third quarter and nine months ended September 30, 2024, as well as provide an update on its Bitcoin holdings after the close of U.S. financial markets on Monday, November 4, 2024.
SANTA CLARA, Calif. , Aug. 26, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced that it has purchased an additional 83 bitcoins for $5.0 million in cash, inclusive of fees and expenses.
Semler Scientific has launched a Bitcoin treasury strategy, purchasing $57 billion for its balance sheet this year. The move marks a major pivot compared to the company's medical technology business. The stock price direction is now tied to the direction of Bitcoin, but core operating trends should keep shares volatile.
SANTA CLARA, Calif. , July 22, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced that it will report financial results for the second quarter and six months ended June 30, 2024, after the close of U.S. financial markets on Monday, August 5, 2024.
SANTA CLARA, Calif. , June 6, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced that it has purchased an additional 247 bitcoins for an aggregate $17 million in cash, inclusive of fees and expenses.
SANTA CLARA, Calif. , May 28, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, announced today that its board of directors has adopted bitcoin as its primary treasury reserve asset.
Semler Scientific, Inc. (NASDAQ:SMLR ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Doug Murphy-Chutorian – Chief Executive Officer Renae Cormier – Chief Financial Officer Jennifer Oliva Herrington – Chief Operating Officer Conference Call Participants Aaron Wukmir – Lake Street Capital Markets Herbert Semler – Semler Health Operator Good afternoon, and welcome to the Semler Scientific 2023 Third Quarter Financial Results Conference Call. All participants will be in a listen-only mode.
Semler Scientific's 1H 2023 was surprisingly strong, with record high fixed-fee and variable-fee revenues. Semler's strong financial performance stands in stark contrast to its stock price, which has languished at a price even below where it was during the pandemic. Short-term, the market is concerned that the Hierarchical Condition Categories (HCC) codes effective in 2024 will reimburse QuantaFlo at a lower clip than in previous years.
Start Time: 16:30 January 1, 0000 4:49 PM ET Semler Scientific, Inc. (NASDAQ:SMLR ) Q2 2023 Earnings Conference Call August 10, 2023, 16:30 PM ET Company Participants Douglas Murphy-Chutorian - CEO Renae Cormier - CFO Conference Call Participants Aaron Wukmir - Lake Street Capital Markets Operator Good afternoon, and welcome to the Semler Scientific 2023 Second Quarter Financial Results Conference Call. All participants will be in a listen-only mode.
What type of business is Semler Scientific?
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.
What sector is Semler Scientific in?
Semler Scientific is in the Healthcare sector
What industry is Semler Scientific in?
Semler Scientific is in the Medical Devices industry
What country is Semler Scientific from?
Semler Scientific is headquartered in United States
When did Semler Scientific go public?
Semler Scientific initial public offering (IPO) was on 21 February 2014
What is Semler Scientific website?
https://www.semlerscientific.com
Is Semler Scientific in the S&P 500?
No, Semler Scientific is not included in the S&P 500 index
Is Semler Scientific in the NASDAQ 100?
No, Semler Scientific is not included in the NASDAQ 100 index
Is Semler Scientific in the Dow Jones?
No, Semler Scientific is not included in the Dow Jones index
When was Semler Scientific the previous earnings report?
No data
When does Semler Scientific earnings report?
The next expected earnings date for Semler Scientific is 04 November 2024